What Lawyers Need to Know About Data-Driven Investigations
Healthcare fraud enforcement is moving beyond the traditional investigation built around whistleblower allegations, isolated billing anomalies, or a single problematic provider. Government agencies are increasingly using claims data, financial records, provider relationships, and patient information to identify suspicious conduct at scale—and to intervene before alleged fraud becomes more difficult to recover.
The Department of Justice’s 2026 National Health Care Fraud Takedown illustrates this shift. The operation charged 455 defendants, including 90 doctors and other licensed professionals, in alleged schemes involving more than $6.5 billion in false claims. DOJ specifically attributed part of the effort to the “cutting-edge use of data analytics to target the worst actors.”
From Anomalies to Networks
Data analytics allows agencies to evaluate billing behavior against broader benchmarks. Investigators can examine sudden increases in claim volume, unusually high reimbursement per patient, geographic outliers, improbable service patterns, and relationships among providers, marketers, laboratories, pharmacies, and corporate entities.
The objective is not necessarily to identify one inaccurate claim. It is to locate a pattern that may reveal an entire network.
The 2026 takedown demonstrates how this approach works. DOJ reported that its Health Care Fraud Unit’s Data Analytics Team detected a spike in payments for amniotic wound allografts. That analysis contributed to prosecutions alleging medically unnecessary procedures, inflated billing, excessive treatment areas, and illegal kickbacks.
Other analytical indicators can be equally revealing. In one behavioral-health case, claims allegedly reflected more than 500 hours of counseling and therapy services per day—an apparent impossibility when compared with the provider’s staffing capacity. Investigators also determined that some patients were hospitalized elsewhere on dates when services were allegedly billed.
These comparisons transform raw claims into evidence of operational reality.
Enforcement Is Becoming Preventive
The most important development may be the government’s increasing focus on stopping payments before they are released. In connection with the 2026 operation, CMS suspended 1,079 providers and revoked the billing privileges of 1,403 providers. HHS-OIG also reported actions involving more than $10 billion in payments that CMS had caught and suspended before funds reached allegedly fraudulent providers.
For counsel, this means an investigation may create immediate business consequences before an indictment or civil complaint is filed. Payment suspension, exclusion, loss of billing privileges, DEA action, and parallel administrative proceedings can threaten an organization’s viability even where criminal liability remains unresolved.
A provider’s first notice may therefore arrive not as a subpoena, but as a payment interruption or credentialing action.
The Investigative Data Set Is Expanding
The government is also combining traditionally separate information sources. DOJ’s Data Fusion Center brings together personnel from the Fraud Division, HHS-OIG, the FBI, and other agencies. Its Financial Intelligence Review Team combines claims analytics with financial analysis, including the movement of alleged proceeds into brokerage accounts, luxury assets, real estate, and related businesses.
This creates a more complete investigative picture. Claims may show what was billed; staffing records may show what could have been provided; hospital records may show where the patient actually was; and financial records may show who benefited.
Lawyers should assume that these categories of information may be analyzed together, even when they are maintained by different departments or entities.
Practical Implications for Counsel
Healthcare counsel should treat data governance as an enforcement issue, not merely an information-technology concern. Effective compliance programs should include:
- Regular review of billing outliers by provider, service line, location, and referral source.
- Documentation that explains unusual volume, reimbursement, or patient-acuity patterns.
- Controls for marketer compensation, ownership relationships, and referral arrangements.
- Reconciliation of claims with staffing capacity, clinical records, scheduling data, and patient-location information.
- A documented process for investigating anomalies and preserving responsive records.
- Periodic testing of algorithmic or automated billing systems for inaccurate coding and unsupported claims.
When an agency inquiry begins, counsel should quickly identify the data architecture behind the claims. That includes understanding who created the records, how systems calculate billing fields, whether data was altered or migrated, and which individuals can explain apparent inconsistencies.
A New Standard of Readiness
Data-driven enforcement does not eliminate the need for legal judgment. An outlier is not proof of fraud, and statistical correlation cannot substitute for evidence of knowledge, intent, medical necessity, or materiality. But analytics can determine which providers receive scrutiny, how investigators frame their theory, and how quickly the government escalates.
The strategic lesson is clear: compliance programs must be capable of detecting the same patterns that enforcement agencies can see. In the current environment, organizations that review only individual claims may miss the larger story their data is telling.